{"id": "1340004897425600514", "creation": 1608317038.0, "user_id": "39742016", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 0, "like_count": 7, "quote_count": 0}}, "text": "Just out\ud83d\udce2\nThe @US_FDA \ud83c\uddfa\ud83c\uddf8approves Selinexor for refractory #MultipleMyeloma and Relugolix for advanced #prostatecancer #PCSM\n\nNot the Approval I have been anxious for all week (cough cough Moderna #COVID19 #Vaccine ) But definitely GREAT News for our patients!!!!!\nThanks @AACR !! https://t.co/qyFj58EDib", "first_save": 1634559108.199414, "hashtags": ["#MULTIPLEMYELOMA", "#PROSTATECANCER", "#PCSM", "#COVID19", "#VACCINE"]}